| J9271 | Injection, pembrolizumab, 1 mg | 4,000 | $40 | $156.1K |
| J9144 | Injection, daratumumab, 10 mg and hyaluronidase‑fihj | 3,780 | $40 | $143.8K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 100 | $110 | $10.6K |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | 70 | $140 | $9K |
| 99215 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the… | 60 | $140 | $8.3K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 50 | $100 | $4.8K |
| 96401 | The provider administers nonhormonal, antineoplastic chemotherapy drugs subcutaneously or intramuscularly to the patient. | 60 | $60 | $3.4K |
| J9041 | Injection, bortezomib, 0.1 mg | 910 | $1 | $2.7K |
| G0498 | Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community… | 10 | $210 | $2.5K |
| 99204 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider… | 20 | $130 | $2.4K |